RPRX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Royalty Pharma PLC

Watchlist Manager

Watchlist

Price: 58.7 USD -0.54% Market Closed

Market Cap: $33.8B

	Royalty Pharma PLC NASDAQ:RPRX	US
R	Rakuten Group Inc XMUN:RAK	JP
E	Erste Group Bank AG DUS:EBO	AT
S	Spearmint Resources Inc CNSX:SPMT	CA
J	JF Technology Bhd KLSE:JFTECH	MY
	Q & M Dental Group (Singapore) Ltd SGX:QC7	SG
	Ningxia Baofeng Energy Group Co Ltd SSE:600989	CN

Profitability Summary

Royalty Pharma PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

68%

Strong 3Y Average Operating Margin

59%

Operating Margin is Increasing

19% > 68%

Exceptional Net Margin

34%

Strong 3Y Average Net Margin

37%

Net Margin is Increasing

11% > 34%

Exceptional Free Cash Flow Margin

19%

Strong 3Y Average Free Cash Flow Margin

27%

Declining Free Cash Flow Margin

22% > 19%

Positive ROE

12%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.